2022 American Transplant Congress » Biomarkers: Clinical Outcomes
Date: Tuesday, June 7, 2022
Time: 7:00pm-8:00pm
Location: Hynes Halls C & D
Session Type: Poster Abstract
Meeting: 2022 American Transplant Congress
- 7:00pm-8:00pm
A Novel Mismatch That Modulates the Innate Alloresponse Risk Stratifies Renal Transplant Patients
- 7:00pm-8:00pm
Acute Tubular Injury and Necrosis Do Not Lead to Meaningful Elevations in Donor-Derived Cell-Free DNA (dd-cfDNA)
- 7:00pm-8:00pm
Analysis of Sars-Cov-2-Specific T-Cell Responses Using Novel Single-Cell Multiplexed Isolight in Covid-19 Convalescents
- 7:00pm-8:00pm
Antibody Response and Molecular Graft Surveillance in Kidney Transplant Recipients Following Sars-CoV-2 Vaccination
- 7:00pm-8:00pm
Association of Pre-Transplant Anti A1 IgM Antibody Titers with Survival Outcomes in A2/A2B to B Kidney Transplantation
- 7:00pm-8:00pm
Baseline Levels and Early Post-Transplant Kinetics of Donor-Derived Cell-Free DNA Following Liver Transplantation
- 7:00pm-8:00pm
Clinical Utility of Donor-Derived Cell-Free DNA During the Period of Recovery of Renal Function After Kidney Transplantation
- 7:00pm-8:00pm
Comparative Analysis of kSORT Assay for Predicting Acute Renal Allograft Rejection Under Belatacept-Based Immunosuppression
- 7:00pm-8:00pm
Delta Changes in Donor-Derived Cell-Free DNA (dd-cfDNA) Complement the Donor Fraction in Kidney Transplant Surveillance
- 7:00pm-8:00pm
Detection of Early Graft Injury After Liver Transplantation with Blood-Bile Ratio of Tacrolimus: The TUBE Trial
- 7:00pm-8:00pm
Diagnosis of Acute Graft Rejection After Kidney Transplantation Using Metabolome Analysis by Liquid Biopsy Approach
- 7:00pm-8:00pm
Do Early Trends of Donor-Derived Cell Free DNA Predict Long Term Kidney Allograft Outcomes?
- 7:00pm-8:00pm
Donor-Derived Cell-Free DNA Trends Before and After Rejection Vary Based on Timing of Rejection
- 7:00pm-8:00pm
Donor-Derived Cell-Free DNA and Gene Expression Profiling for Surveillance of Renal Allograft Injury and Rejection
- 7:00pm-8:00pm
Donor/Recipient Variabilities and Dd-cfdna Level
- 7:00pm-8:00pm
Evaluating Long Term Outcomes in Kidney Transplant Patients with TruGraf Gene Expression and TRAC Dd-cfdna in the TRULO Study
- 7:00pm-8:00pm
Galectin-3 Discriminates Patients with Advanced Cirrhosis and Predicts Post-Liver Transplant Infectious Complications
- 7:00pm-8:00pm
Impact of HMGB-1 SNPs on Comorbidities and Postoperative Complications in Liver Transplant Recipients
- 7:00pm-8:00pm
Impact of Sars-CoV-2 Vaccination on Donor-Derived Cell Free DNA Levels in Renal Transplant Recipients
- 7:00pm-8:00pm
Inflammation After Kidney Transplantation Is Associated With Overall- And Death-censored Graft Loss
- 7:00pm-8:00pm
Interleukin-31 (IL-31) and Leukemia Inhibitory Factor (LIF) Are Upregulated in Acute Rejection of Kidney Allograft
- 7:00pm-8:00pm
Kidney Allograft Injury is Reflected in the DNA Cargo of Urinary Extracellular Vesicles
- 7:00pm-8:00pm
Kinetics of dd-cfDNA in Kidney Transplant Recipients Following Sars-CoV-2 Vaccination Booster Administration
- 7:00pm-8:00pm
Mycophenolate Mofetil-Related Diarrhea and Beta-Glucuronidase Activity Following Kidney Transplantation
- 7:00pm-8:00pm
Myeloid Molecular Signature of Ischemia-Reperfusion Injury in Human Liver Transplantation
- 7:00pm-8:00pm
Novel Peripheral Molecular Markers Predict Premature Graft Loss: Lessons Learned from Operational Tolerance Assessment
- 7:00pm-8:00pm
PCR-Enhanced Performance Characteristics of TruGraf Gene Expression Profile in Kidney Transplant
- 7:00pm-8:00pm
Peripheral Blood Immune Cell Profiles of Corneal Transplant with and without Acute Rejection
- 7:00pm-8:00pm
Plasma Donor-Derived Cell-Free DNA Longitudinal Kinetics After Kidney Transplantation in Children
- 7:00pm-8:00pm
Plasma Galectin-3 is Predictive of Post-Transplant Infection in Pediatric Liver Transplant Recipients
- 7:00pm-8:00pm
Post-Operative Day 1 Galectin-3 is Predictive of Early Allograft Dysfunction in Liver Transplantation
- 7:00pm-8:00pm
RBBP7 as a Novel Biomarker for the Molecular Diagnosis of BK Virus-Associated Nephropathy
- 7:00pm-8:00pm
Re-Examining the Optimal Threshold for Donor Derived Cell Free DNA in Renal Allograft Rejection
- 7:00pm-8:00pm
Significance of Gene Polymorphism on Infectious Complications and Rejection After Liver Transplantation
- 7:00pm-8:00pm
Technology-Driven Performance Improvement of a Biomarker Panel in Kidney Transplant: OmniGraf
- 7:00pm-8:00pm
The Effect of Tacrolimus and Mycophenolic Acid on Torque Teno Virus Loads in Kidney Transplant Recipients
- 7:00pm-8:00pm
The Evolution of Hypogammaglobulinemia in Kidney Transplant Recipients and Its Associated Risk Factors
- 7:00pm-8:00pm
The Prediction of Renal Allograft Rejection by Time-Dependent Two-Signature Predictors
- 7:00pm-8:00pm
Trends in Donor Derived Cell Free DNA Before and After Cellular and Antibody Mediated Rejection
« View all sessions from the 2022 American Transplant Congress